Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Depot vs Oral Naltrexone for Opiate Dependence
NCT00577408Phase 3Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Sep 2007
- Primary completion
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in opioid use disorder (OUD), sponsored by New York State Psychiatric Institute. Started Sep 2007; status: completed.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00577408.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00577408.